Neurocrine Biosciences
NBIX
#1546
Rank
ยฃ8.55 B
Marketcap
ยฃ85.80
Share price
-1.92%
Change (1 day)
-20.42%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): ยฃ0.39 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are ยฃ2.35 Billion. , an increase over its 2023 earnings that were of ยฃ0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 ยฃ0.39 B64.57%
2023 ยฃ0.24 B41.13%
2022 ยฃ0.17 B73.74%
2021 ยฃ98.44 M-8.82%
2020 ยฃ0.10 B77.78%
2019 ยฃ60.72 M49.83%
2018 ยฃ40.53 M-142.57%
2017 -ยฃ95.21 Million-14.73%
2016 -ยฃ0.12 Billion53.15%
2015 -ยฃ72.91 Million46.25%
2014 -ยฃ49.85 Million29.66%
2013 -ยฃ38.45 Million-3530.8%
2012 ยฃ1.12 M-95.73%
2011 ยฃ26.25 M
2009 -ยฃ36.91 Million-45.38%
2008 -ยฃ67.57 Million-58.87%
2007 -ยฃ0.17 Billion87.3%
2006 -ยฃ87.7 Million351.97%
2005 -ยฃ19.41 Million-52.09%
2004 -ยฃ40.51 Million-10.98%
2003 -ยฃ45.5 Million
2001 -ยฃ33.97 Million
1999 -ยฃ15.32 Million108.32%
1998 -ยฃ7.36 Million
1996 ยฃ2.24 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ14.87 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.20 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ20.85 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.81 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.87 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.37 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ5.81 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ32.33 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA